130 related articles for article (PubMed ID: 35213813)
1. Is Medicaid Expansion Associated with Improved Nonmetastatic Colon Cancer Survival? An Analysis of the National Cancer Database.
Reitz ACW; Switchenko JM; Gillespie TW
Am Surg; 2023 May; 89(5):1764-1773. PubMed ID: 35213813
[TBL] [Abstract][Full Text] [Related]
2. Association of time to resection with survival in patients with colon cancer.
Sakowitz S; Bakhtiyar SS; Verma A; Ebrahimian S; Vadlakonda A; Mabeza RM; Lee H; Benharash P
Surg Endosc; 2024 Feb; 38(2):614-623. PubMed ID: 38012438
[TBL] [Abstract][Full Text] [Related]
3. Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients.
Shi L; Suh W; Kavanaugh MM; Mills G; Thayer S; Shi R
Cureus; 2021 Jun; 13(6):e15748. PubMed ID: 34285854
[TBL] [Abstract][Full Text] [Related]
4. Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma.
Jain V; Venigalla S; Sebro RA; Karakousis GC; Wilson RJ; Weber KL; Shabason JE
Cancer Med; 2019 Oct; 8(14):6295-6304. PubMed ID: 31483578
[TBL] [Abstract][Full Text] [Related]
5. Medicaid Expansion and Mortality Among Patients With Breast, Lung, and Colorectal Cancer.
Lam MB; Phelan J; Orav EJ; Jha AK; Keating NL
JAMA Netw Open; 2020 Nov; 3(11):e2024366. PubMed ID: 33151317
[TBL] [Abstract][Full Text] [Related]
6. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer.
Cabo J; Shu X; Shu XO; Parikh A; Bailey C
J Surg Res; 2020 Jan; 245():265-272. PubMed ID: 31421372
[TBL] [Abstract][Full Text] [Related]
7. Association of Medicaid expansion with racial disparities in cancer stage at presentation.
Snyder RA; Hu CY; DiBrito SR; Chang GJ
Cancer; 2022 Sep; 128(18):3340-3351. PubMed ID: 35818763
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
9. Association Between Medicaid Expansion and Diagnosis and Management of Colon Cancer.
Hoehn RS; Rieser CJ; Phelos H; Sabik LM; Nassour I; Paniccia A; Zureikat AH; Tohme ST
J Am Coll Surg; 2021 Feb; 232(2):146-156.e1. PubMed ID: 33242599
[TBL] [Abstract][Full Text] [Related]
10. Changes in the Proportion of Patients Presenting With Early Stage Colon Cancer Over Time Among Medicaid Expansion and Nonexpansion States: A Cross-sectional Study.
Hao SB; Snyder RA; Irish WD; Parikh AA
Dis Colon Rectum; 2022 Sep; 65(9):1084-1093. PubMed ID: 34803146
[TBL] [Abstract][Full Text] [Related]
11. Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer.
Khalil L; Gao X; Switchenko JM; Alese OB; Akce M; Wu C; Diab M; El-Rayes BF; Shaib WL
Oncologist; 2022 Sep; 27(9):740-750. PubMed ID: 35648074
[TBL] [Abstract][Full Text] [Related]
12. Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.
Fabregas JC; Carter BT; Lutzky J; Robinson WR; Brant JM
J Racial Ethn Health Disparities; 2022 Dec; 9(6):2291-2299. PubMed ID: 34648145
[TBL] [Abstract][Full Text] [Related]
13. A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database.
Reif de Paula T; Gorroochurn P; Simon HL; Haas EM; Keller DS
Colorectal Dis; 2022 Jan; 24(1):40-49. PubMed ID: 34605166
[TBL] [Abstract][Full Text] [Related]
14. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
16. Association Between Primary Payer Status and Survival in Patients With Stage III Colon Cancer: An National Cancer Database Analysis.
Ahmed A; Tahseen A; England E; Wolfe K; Simhachalam M; Homan T; Sitenga J; Walters RW; Silberstein PT
Clin Colorectal Cancer; 2019 Mar; 18(1):e1-e7. PubMed ID: 30297265
[TBL] [Abstract][Full Text] [Related]
17. Racial disparities in colon cancer survival: A propensity score matched analysis in the United States.
Azin A; Guidolin K; Chadi SA; Quereshy FA
Surgery; 2022 Apr; 171(4):873-881. PubMed ID: 35078631
[TBL] [Abstract][Full Text] [Related]
18. Impact of the affordable care act's medicaid expansion on presentation stage and perioperative outcomes of colorectal cancer.
Sharon CE; Song Y; Straker RJ; Kelly N; Shannon AB; Kelz RR; Mahmoud NN; Saur NM; Miura JT; Karakousis GC
J Surg Oncol; 2022 Dec; 126(8):1471-1480. PubMed ID: 35984366
[TBL] [Abstract][Full Text] [Related]
19. Impact of delay to surgery on survival in stage I-III colon cancer.
Grass F; Behm KT; Duchalais E; Crippa J; Spears GM; Harmsen WS; Hübner M; Mathis KL; Kelley SR; Pemberton JH; Dozois EJ; Larson DW
Eur J Surg Oncol; 2020 Mar; 46(3):455-461. PubMed ID: 31806516
[TBL] [Abstract][Full Text] [Related]
20. Where you live matters: A National Cancer Database study of Medicaid expansion and endometrial cancer outcomes.
Barrington DA; Sinnott JA; Calo C; Cohn DE; Cosgrove CM; Felix AS
Gynecol Oncol; 2020 Aug; 158(2):407-414. PubMed ID: 32527568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
